Found 67 matching trials
Anti-alpha-actinin Antibodies and Lupus Nephritis Activity
N/ALupus nephritis (LN) develops in 30-60% of systemic lupus erythematosus (SL...
Location
Multiple Locations
Treatments Being Tested
renal biopsyserum anti-alpha-actinin antibodiesCBC, serum creatinine and urea, estimated GFR, ESR, CRP, urine analysis, ANA, anti dsDNA, C3 & C4, serum albumin, 24-hrs urinary protein, and U. ACR Efficacy and Safety of Infliximab for Immune Checkpoint Inhibitor Induced Colitis
PHASE3The goal of this clinical trial is to assess whether the early introduction...
Location
Department of Oncology, Aalborg University Hospital
Testing Immunosuppression Threshold in Renal Allografts To Extend eGFR
NAThis study evaluates the addition of "Kidney Solid Organ Rejection Test" (k...
Location
National Institute of Medical Sciences and Health Salvador Zubiran
Anti-T-Lymphocyte Globulin (ATG) in Renal Transplantation of Kidneys With a Non-Heart-Beating (NHB) Donor
PHASE3One of the greatest problems in renal transplantation is the shortage of do...
Location
UMC St Radboud Hospital
RCT of Nintedanib in Fibrotic Sarcoidosis
PHASE4Sarcoidosis is generally managed with outdoor immune modulatory drugs, most...
Location
Postgraduate Institute of Medical Education and Research
Melphalan, Fludarabine, and Alemtuzumab Followed by Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer
PHASE2RATIONALE: Giving low doses of chemotherapy, such as melphalan and fludarab...
Location
Memorial Sloan-Kettering Cancer Center
A Study of KZR-616 in Patients With SLE With and Without Lupus Nephritis
PHASE1This was a Phase 1b/2, multi-center study in which patients received KZR-61...
Location
Academic Medical Research Institute
Trial to Study Anti- HCMV Therapy in Breast Cancer Patients With Progressive Intracranial Metastases and CMV Infection
PHASE2This is a phase II trial with an initial safety lead-in evaluating the effi...
Location
Houston Methodist Neal Cancer Center
Study in Recipients of Renal Transplant Allograft to Evaluate the Impact of Two Immunosuppressive Regimens
NAThe immune system is the body's defense against infection and other disease...
Location
Northwestern Memorial Hospital
Targeting Acute Myeloid Leukemia Immunosuppressive Microenvironment by combinedIDO1 Inhibition and PD-1 Blockade
N/AThe combination of azacitidine and venetoclax is currently considered a the...
Location
IRCCS Azienda Ospedaliero-Universitaria di Bologna